Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro.

In this week’s edition of InnovationRx, we look at Eli Lilly’s ... taken the market by storm. Lilly’s tirzepatide drugs, Zepbound for obesity and Mounjaro for diabetes, both of which are ...

as well as 10,000 construction jobs during this process. Since 2020, Eli Lilly marked about $50 billion in spending to keep up with the increase in demand for its GLP-1 medications, which are Mounjaro ...